Literature DB >> 27795557

Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation.

G Berger1, E van den Berg2, B Sikkema-Raddatz2, K M Abbott2, R J Sinke2, L B Bungener3, A B Mulder3, E Vellenga1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27795557     DOI: 10.1038/leu.2016.310

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.

Authors:  Daria V Babushok; Monica Bessler; Timothy S Olson
Journal:  Leuk Lymphoma       Date:  2015-12-23

2.  Loss of quiescence and impaired function of CD34(+)/CD38(low) cells one year following autologous stem cell transplantation.

Authors:  Carolien M Woolthuis; Annet Z Brouwers-Vos; Gerwin Huls; Joost Th M de Wolf; Jan Jacob Schuringa; Edo Vellenga
Journal:  Haematologica       Date:  2013-09-13       Impact factor: 9.941

3.  Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes.

Authors:  Felicitas Thol; Inna Friesen; Frederik Damm; Haiyang Yun; Eva M Weissinger; Jürgen Krauter; Katharina Wagner; Anuhar Chaturvedi; Amit Sharma; Martin Wichmann; Gudrun Göhring; Christiane Schumann; Gesine Bug; Oliver Ottmann; Wolf-Karsten Hofmann; Brigitte Schlegelberger; Michael Heuser; Arnold Ganser
Journal:  J Clin Oncol       Date:  2011-05-16       Impact factor: 44.544

4.  Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.

Authors:  Maya Lewinsohn; Anna L Brown; Luke M Weinel; Connie Phung; George Rafidi; Ming K Lee; Andreas W Schreiber; Jinghua Feng; Milena Babic; Chan-Eng Chong; Young Lee; Agnes Yong; Graeme K Suthers; Nicola Poplawski; Meryl Altree; Kerry Phillips; Louise Jaensch; Miriam Fine; Richard J D'Andrea; Ian D Lewis; Bruno C Medeiros; Daniel A Pollyea; Mary-Claire King; Tom Walsh; Siobán Keel; Akiko Shimamura; Lucy A Godley; Christopher N Hahn; Jane E Churpek; Hamish S Scott
Journal:  Blood       Date:  2015-12-28       Impact factor: 22.113

5.  Cytarabine dose for acute myeloid leukemia.

Authors:  Bob Löwenberg; Thomas Pabst; Edo Vellenga; Wim van Putten; Harry C Schouten; Carlos Graux; Augustin Ferrant; Pieter Sonneveld; Bart J Biemond; Alois Gratwohl; Georgine E de Greef; Leo F Verdonck; Martijn R Schaafsma; Michael Gregor; Matthias Theobald; Urs Schanz; Johan Maertens; Gert J Ossenkoppele
Journal:  N Engl J Med       Date:  2011-03-17       Impact factor: 91.245

6.  Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.

Authors:  Reinhard Kalb; Kornelia Neveling; Holger Hoehn; Hildegard Schneider; Yvonne Linka; Sat Dev Batish; Curtis Hunt; Marianne Berwick; Elsa Callen; Jordi Surralles; Jose A Casado; Juan Bueren; Angeles Dasi; Jean Soulier; Eliane Gluckman; C Michel Zwaan; Rosalina van Spaendonk; Gerard Pals; Johan P de Winter; Hans Joenje; Markus Grompe; Arleen D Auerbach; Helmut Hanenberg; Detlev Schindler
Journal:  Am J Hum Genet       Date:  2007-04-06       Impact factor: 11.025

7.  Two novel germline DDX41 mutations in a family with inherited myelodysplasia/acute myeloid leukemia.

Authors:  Ruijuan Li; Nara Sobreira; P Dane Witmer; Keith W Pratz; Evan M Braunstein
Journal:  Haematologica       Date:  2016-03-04       Impact factor: 9.941

8.  Acquired mutations in TET2 are common in myelodysplastic syndromes.

Authors:  Saskia M C Langemeijer; Roland P Kuiper; Marieke Berends; Ruth Knops; Mariam G Aslanyan; Marion Massop; Ellen Stevens-Linders; Patricia van Hoogen; Ad Geurts van Kessel; Reinier A P Raymakers; Eveline J Kamping; Gregor E Verhoef; Estelle Verburgh; Anne Hagemeijer; Peter Vandenberghe; Theo de Witte; Bert A van der Reijden; Joop H Jansen
Journal:  Nat Genet       Date:  2009-05-31       Impact factor: 38.330

9.  Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.

Authors:  Klaus H Metzeler; Tobias Herold; Maja Rothenberg-Thurley; Susanne Amler; Maria C Sauerland; Dennis Görlich; Stephanie Schneider; Nikola P Konstandin; Annika Dufour; Kathrin Bräundl; Bianka Ksienzyk; Evelyn Zellmeier; Luise Hartmann; Philipp A Greif; Michael Fiegl; Marion Subklewe; Stefan K Bohlander; Utz Krug; Andreas Faldum; Wolfgang E Berdel; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann; Jan Braess; Karsten Spiekermann
Journal:  Blood       Date:  2016-06-10       Impact factor: 22.113

10.  Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.

Authors:  Jane E Churpek; Khateriaa Pyrtel; Krishna-Latha Kanchi; Jin Shao; Daniel Koboldt; Christopher A Miller; Dong Shen; Robert Fulton; Michelle O'Laughlin; Catrina Fronick; Iskra Pusic; Geoffrey L Uy; Evan M Braunstein; Mark Levis; Julie Ross; Kevin Elliott; Sharon Heath; Allan Jiang; Peter Westervelt; John F DiPersio; Daniel C Link; Matthew J Walter; John Welch; Richard Wilson; Timothy J Ley; Lucy A Godley; Timothy A Graubert
Journal:  Blood       Date:  2015-10-22       Impact factor: 22.113

View more
  28 in total

Review 1.  DDX41-related myeloid neoplasia.

Authors:  Jaroslaw P Maciejewski; Richard A Padgett; Anna L Brown; Carsten Müller-Tidow
Journal:  Semin Hematol       Date:  2017-04-21       Impact factor: 3.851

2.  Novel germline missense DDX41 variant in a patient with an adult-onset myeloid neoplasm with excess blasts without dysplasia.

Authors:  Filippo Pinto E Vairo; Alejandro Ferrer; Elizabeth Cathcart-Rake; Rebecca L King; Matthew T Howard; David S Viswanatha; Eric W Klee; Abhishek A Mangaonkar; Mrinal M Patnaik
Journal:  Leuk Lymphoma       Date:  2018-11-08

3.  Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation.

Authors:  S Kobayashi; A Kobayashi; Y Osawa; S Nagao; K Takano; Y Okada; N Tachi; M Teramoto; T Kawamura; T Horiuchi; S Kato; T Maekawa; T Yamamura; J Watanabe; Y Harada; H Harada; K Sato; F Kimura
Journal:  Leukemia       Date:  2017-02-14       Impact factor: 11.528

4.  Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia.

Authors:  Jianbiao Zhou; Wee-Joo Chng
Journal:  Stem Cell Investig       Date:  2017-02-09

5.  Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.

Authors:  Fei Yang; Tauangtham Anekpuritanang; Richard D Press
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

Review 6.  Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).

Authors:  Anna L Brown; Christopher N Hahn; Hamish S Scott
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

Review 7.  Nucleic acid sensing pattern recognition receptors in the development of colorectal cancer and colitis.

Authors:  Liangmei He; Yayun Chen; Yuanbing Wu; Ying Xu; Zixiang Zhang; Zhiping Liu
Journal:  Cell Mol Life Sci       Date:  2017-02-21       Impact factor: 9.261

Review 8.  Myeloid neoplasms with germline DDX41 mutation.

Authors:  Jesse J C Cheah; Christopher N Hahn; Devendra K Hiwase; Hamish S Scott; Anna L Brown
Journal:  Int J Hematol       Date:  2017-05-25       Impact factor: 2.490

9.  ETV6-related thrombocytopenia and leukemia predisposition.

Authors:  Jorge Di Paola; Christopher C Porter
Journal:  Blood       Date:  2019-06-27       Impact factor: 22.113

Review 10.  Hematological Malignancies in Adults With a Family Predisposition.

Authors:  Tilmann Bochtler; Georg-Martin Haag; Sarah Schott; Matthias Kloor; Alwin Krämer; Carsten Müller-Tidow
Journal:  Dtsch Arztebl Int       Date:  2018-12-14       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.